Silica–gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity

Autor: Ulla Hynönen, Markus Linder, Wei He, Airi Palva, Katrina Nordström, Yaping Meng, Pezhman Mohammadi, Simo-Pekka Hannula, Qingling Feng, Dina A. Mosselhy
Přispěvatelé: Veterinary Biosciences, Departments of Faculty of Veterinary Medicine
Rok vydání: 2018
Předmět:
0301 basic medicine
Embryo
Nonmammalian

Antibiotics
Pharmaceutical Science
MRSA
CONTROLLED-RELEASE
02 engineering and technology
SILVER NANOPARTICLES
SUSCEPTIBILITY
medicine.disease_cause
0302 clinical medicine
International Journal of Nanomedicine
BONE RESEARCH
Drug Discovery
antibacterial and antibiofilm effects
VITRO
1183 Plant biology
microbiology
virology

Original Research
0303 health sciences
Chemistry
General Medicine
Silicon Dioxide
021001 nanoscience & nanotechnology
Anti-Bacterial Agents
3. Good health
DIFFERENTIATION
INFECTIONS
Staphylococcus aureus
Larva
Toxicity
Gentamicin
Erratum
SiO2
0210 nano-technology
medicine.drug
Methicillin-Resistant Staphylococcus aureus
medicine.drug_class
Biophysics
Bioengineering
Microbial Sensitivity Tests
gentamicin
Microbiology
Biomaterials
03 medical and health sciences
Antibiotic resistance
In vivo
Drug Resistance
Bacterial

Toxicity Tests
Escherichia coli
medicine
Animals
Humans
ta216
ta215
030304 developmental biology
ANTIMICROBIAL ACTIVITY
SOL-GEL
ZEBRAFISH
Organic Chemistry
Biofilm
biochemical phenomena
metabolism
and nutrition

030104 developmental biology
Biofilms
nanotoxicity
Nanoparticles
Gentamicins
030217 neurology & neurosurgery
Zdroj: Mosselhy, D A, He, W, Hynönen, U, Meng, Y, Mohammadi, P, Palva, A, Feng, Q, Hannula, S-P, Nordström, K & Linder, M B 2018, ' Silica–gentamicin nanohybrids : combating antibiotic resistance, bacterial biofilms, and in vivo toxicity ', International Journal of Nanomedicine, vol. 13, pp. 7939-7957 . https://doi.org/10.2147/IJN.S182611
International Journal of Nanomedicine
ISSN: 1178-2013
Popis: Dina A Mosselhy,1–3 Wei He,4 Ulla Hynönen,5 Yaping Meng,6 Pezhman Mohammadi,1 Airi Palva,5 Qingling Feng,7 Simo-Pekka Hannula,2 Katrina Nordström,1 Markus B Linder11Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, Espoo, Finland; 2Department of Chemistry and Materials Science, School of Chemical Engineering, Aalto University, Espoo, Finland; 3Fish Diseases Department, Microbiological Unit, Animal Health Research Institute, Dokki, Giza 12618, Egypt; 4School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing, People’s Republic of China; 5Department of Veterinary Biosciences, Division of Veterinary Microbiology and Epidemiology, University of Helsinki, Helsinki, Finland; 6State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, People’s Republic of China; 7State Key Laboratory of New Ceramics and Fine Processing, School of Materials Science and Engineering, Tsinghua University, Beijing, People’s Republic of China Introduction: Antibiotic resistance is a growing concern in health care. Methicillin-resistant Staphylococcus aureus (MRSA), forming biofilms, is a common cause of resistant orthopedic implant infections. Gentamicin is a crucial antibiotic preventing orthopedic infections. Silica–gentamicin (SiO2-G) delivery systems have attracted significant interest in preventing the formation of biofilms. However, compelling scientific evidence addressing their efficacy against planktonic MRSA and MRSA biofilms is still lacking, and their safety has not extensively been studied.Materials and methods: In this work, we have investigated the effects of SiO2-G nanohybrids against planktonic MRSA as well as MRSA and Escherichia coli biofilms and then evaluated their toxicity in zebrafish embryos, which are an excellent model for assessing the toxicity of nanotherapeutics.Results: SiO2-G nanohybrids inhibited the growth and killed planktonic MRSA at a minimum concentration of 500 µg/mL. SiO2-G nanohybrids entirely eradicated E. coli cells in biofilms at a minimum concentration of 250 µg/mL and utterly deformed their ultrastructure through the deterioration of bacterial shapes and wrinkling of their cell walls. Zebrafish embryos exposed to SiO2-G nanohybrids (500 and 1,000 µg/mL) showed a nonsignificant increase in mortality rates, 13.4±9.4 and 15%±7.1%, respectively, mainly detected 24 hours post fertilization (hpf). Frequencies of malformations were significantly different from the control group only 24 hpf at the higher exposure concentration.Conclusion: Collectively, this work provides the first comprehensive invivo assessment of SiO2-G nanohybrids as a biocompatible drug delivery system and describes the efficacy of SiO2-G nanohybrids in combating planktonic MRSA cells and eradicating E. coli biofilms.Keywords: SiO2, gentamicin, MRSA, antibacterial and antibiofilm effects, nanotoxicity, zebrafishErratumfor this paper has been published
Databáze: OpenAIRE